PCI Biotech: Mandatory notification of trade

Lysaker, June 30 2015 -

The primary insider and Chief Business Development Officer, Gaël L'Hévéder, has
purchased a total of 10 000 shares. 8 000 shares are purchased at a price of NOK
6.00 per share and 2 000 shares at a price of NOK 5.45 per share. After this the
primary insider, Gaël L'Hévéder, holds a total of 10 000 shares and 85 000
unexercised options in the company, corresponding to 70 000 unexercised options
at a strike price of NOK 14.52 and 15 000 unexercised options at a strike price
of NOK 12.53 in the company.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


[HUG#1932713]